CrossRef Non-alcoholic Fatty Liver Disease and Its Association With Left Ventricular Diastolic Dysfunction: A Systematic Review Namra V Gohil, Nida Tanveer, Vijaya Krishna Makkena, Arturo P Jaramillo, Babatope L Awosusi, Javaria Ayyub, Karan Nareshbhai Dabhi, Tuheen Sankar Nath Cureus.2023;[Epub] CrossRef Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status Wangyan Jiang, Zhelong Liu, Shaohua Liu, Tingting Du Frontiers in Endocrinology.2023;[Epub] CrossRef Non-Alcoholic Fatty Liver Disease and Echocardiographic Parameters of Left Ventricular Diastolic Function: A Systematic Review and Meta-Analysis Athina Goliopoulou, Panagiotis Theofilis, Evangelos Oikonomou, Artemis Anastasiou, Panteleimon Pantelidis, Maria Ioanna Gounaridi, Georgios E
And absent more rigorous studies, the team warned, it will remain difficult to convince the broader medical community that this so-called wonderful compound meets the criteria of a legitimate therapeutic agent. But it turns out, one group had begun to give it a go anyway
The Development of Hybrid Secretagogues Researchers at Novo Nordisk explored hybrid molecules combining structural elements of ipamorelin with NN703 (another GH secretagogue) to create compounds with enhanced potency while retaining selectivity
Previously the two-hit theory was prevalent and central to the progression of the disease, however, this theory is considered outdated (Alonso et al., 2017[6]
It also causes contraction of the iris sphincter muscle, which constricts the pupil, but maintains some pupillary response to light
